FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for theproduction of gene therapy products for clinical and commercial supply.

Life Sciences

Biotechnology

Research

FinVector Oy

FinVector Oy's headquarters in Kuopio, Finland

��

Description

People (3)

Jobs (0)

Other offices

��������

Description

People (3)

Jobs (0)

Other offices

��